Clinical Trial Update: A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration [Phase 4]

View source ↗

Summary

Phase 4 study of VIVITROL (naltrexone extended-release) in opioid dependence was completed, with results posted in 2015. The trial evaluated prevention of re-ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Opioid Dependence | Phase 4 | Status: COMPLETED | Results posted: 2015-07-13